| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Public Statement |
| Series Details | EMA/763463/2009 (16.4.10) |
| Publication Date | 16/04/2010 |
| Content Type | News |
|
The European Medicines Agency (EMA) and its Committee for Advanced Therapies issued a public statement on 16 April 2010, urging that access to medicinal products containing stem cells should only be under certain controlled conditions. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/pdfs/human/cat/76346309en.pdf |
| Subject Categories | Business and Industry, Health |
| Countries / Regions | Europe |
